急性发作期慢性阻塞性肺病53例营养状况临床分析
|
摘要
目的:探讨急性发作期慢性阻塞性肺病患者的营养状况对机体免疫和通气功能的影响,为加强慢性阻塞性肺病合并呼吸衰竭病人的营养支持治疗提供依据,以及时进行有效的营养干预,从而提高其生活质量,减少发病次数。
方法:收集2008年3月至2009年3月因COPD急性加重(AECOPD)入住中日联谊医院呼吸内科53例患者,并除外肝、肾、消化道疾病及结核、恶性肿瘤、甲状腺功能亢进等消耗性疾病。检测如下六项指标(1)实际体重与标准体重百分比(%IBW);(2)血清白蛋白(ALB);(3)外周血淋巴细胞计数(TLC)=淋巴细胞百分数X白细胞计数; (4)肺功能:用意大利进口肺量计,检测第1秒用力呼气量(FEV1),并计算第1秒用力呼气量与用力肺活量百分比(FEV1%); (5)用血气分析仪测定患者的动脉血PH值、氧分压(P02)、二氧化碳分压(PC02);(6)住院天数。依据轻度: FEV1 / FVC < 70 %、FEV1≥80 %预计值,有或无慢性咳嗽、咳痰症状;极重度: FEV1 / FVC < 70 %、FEV1 < 30 %预计值,或FEV1 < 50 %预计值,并伴有慢性呼吸衰竭或右心衰竭临床表现,将慢性阻塞性肺病分为轻度及极重度两组,对比分析其营养、免疫、肺功能、血气及住院情况。
结果:实际体重占理想体重的百分比(%IBW)、一秒用力呼气量(FEV1)及FEV1和用力肺活量(FVC)百分比、动脉血二氧化碳分压(PCO2)、住院天数两组之间有显著性差异(P<0.05)。
结论:慢性阻塞性肺病患者的营养状况和病情严重程度密切相关,加强慢性阻塞性肺病患者的营养状况可改善其预后。
Chronic obstructive pulmonary disease (COPD) is a kind of disease that could be prevented and treated, and it holds a characteristics that the airflow can berestricted .But the airflow limitation was not fully reversible ,it develops progressively, in relation to the lung's abnormal inflammations reaction to the harmful gases and harmful particles . Because of its high morbidity and mortality, and there is an increasing trend year by year, COPD has serious negative impact on the labor force and quality of life. COPD is currently the world's fourth cause of death, the World Bank / WHO announced COPD will be the fifth financial burden of the diseases in the world's by 2020 . In our country COPD is also an important chronic respiratory diseases which seriously endangers the health of the people, and is the most common cause leading to chronic respiratory failure and chronic pulmonary heart disease . The main damage of COPD is in lung ,but it may also cause the systemic effects . To chronic obstructive pulmonary disease patients, their exercise endurance was reduced, activity was restricted, quality of life was decreased. Recent study found that in COPD patients skeletal muscle dysfunction and weight loss are widespread, and is associated with lower endurance exercise. Non-fat weight loss of patients with COPD can affect the respiratory muscles and peripheral muscle function, exercise capacity, health status and prognosis. Reducing body mass index in patients with acute exacerbation of COPD is a bad indicator, increase their hospitalization rate, mortality and rate of mechanical ventilation, and the survival time Closely related to their body mass index .
Acute stage in patients with chronic obstructive pulmonary disease has often accompanied by malnutrition, incidence of it is up to 50.6% ~ 69.9% and the weight loss is its outstanding performance , 60 percent of them weight less than ideal body weight, by the chronic long-term consumption of basic pulmonary disease or absorption barriers, reduce consumption or acute severe lung infection caused by the high metabolic state, manifested as respiratory muscle atrophy, decreased contractile force, endurance and reduce the pulmonary defense functional decline, etc.. Surfactant reduced, and thus easy to alveolar collapse, and severe malnutrition make the respiratory center,s reactivity to hypoxia and hyperpyemia reduce, all the above are easily induced by respiratory failure. In addition, the patient with mechanical ventilation will become difficult to remove the machince. Therefore, nutrition therapy for chronic obstructive pulmonary disease patients with respiratory failure is an important instrument.
Objective: To investigate the acute exacerbation of chronic obstructive pulmonary disease in patients with nutritional status on immune function and ventilation, as well as provide the basis for the treatment of nutritional support for patients with chronic obstructive pulmonary disease who has respiratory failure, conduct effective nutrition intervention, and thus improve their quality of life, reduce the incidence of the number.
Methods: From March 2008 to March 2009 ,there were 53 patients who were by AECOPD due to China-Japen Union Hospital of Jilin University,and except patient with liver, kidney, digestive tract diseases and tuberculosis, cancer, hyperthyroidism etc. The definition of acute exacerbation of the COPD is the continued deterioration beyond the day-to-day situation and the COPD patients who need to change the basis of the conventional drug , in the disease process, patients usually with the aggravation of cough、sputum、shortness of breath and (or) pant in short-term, the increase of sputum volume ,in viscosity purulent or purulent, inflammation may be associated with fever. COPD in line with the diagnosis and treatment guidelines of Chronic Obstructive Pulmonary Disease Study Group which is attached to the Pulmonary Disease Study Group of Chinese Medical Association to set down in 2007.Detected the following six index:(1) the percentage of actual body weight to standard body weight (% IBW); (2) serum albumin (ALB); (3) peripheral blood lymphocyte count (TLC) = lymphocyte percentage X white blood cell count;: (4) pulmonary function and blood gas analysis: Using Italy spirometer to detect the first one second forced expiratory volume (FEV1), and calculate percentage of the first 1 second forced expiratory volume to FVC (FEV1%); (5) by blood gas analyzer Determination of arterial blood in patients with PH value, partial pressure of oxygen (P02), carbon dioxide partial pressure (PC02); (6) hospital day(HOD). Based on mild: FEV1 / FVC <70%, FEV1≥80% expected value, with or without chronic cough and expectoration symptoms; severe: FEV1 / FVC <70%, FEV1 <30% expected value, or FEV1 <50% expected value, and with chronic respiratory failure or clinical manifestations of right heart failure, chronic obstructive pulmonary disease will be divided into mild and severe groups, the comparative analysis of its nutrition, immunization, lung function and blood gas situation.
Results: The actual body weight accounted for the percentage of ideal body weight (% IBW), forced expiratory volume in one second (FEV1) and FEV1 to forced vital capacity (FVC) percentage,rterial carbon dioxide partial pressure (PCO2),hospital day (HOD)between the two groups were significantly different (P <0.05).
Conclusion: 1. COPD is a high incidence of common, frequently-occurring disease, and is often accompanied by malnutrition, in the acute stage due to nutrient digestion and absorption barriers, reducing consumption and increasing consumption, malnutrition is more serious.
2. Chronic obstructive pulmonary disease patients with the nutritional status of their cellular immune function and respiratory muscle strength and severity of disease are closely related, with the airway resistance in patients with the progressive increase in respiratory muscle must accompanied by the respiratory function improve, that is easy, following energy consumption , heat demand for a more timely manner to the corresponding supplement, together with the causes of hypoxia, such as aggravated respiratory muscle deterioration in energy metabolism, resulting in negative energy balance, thus affecting the prognosis.
3. Acute exacerbation of COPD patients with timely and effective nutritional intervention can improve the patient's immune function and ventilation, and reduce mortality in patients.
方法:收集2008年3月至2009年3月因COPD急性加重(AECOPD)入住中日联谊医院呼吸内科53例患者,并除外肝、肾、消化道疾病及结核、恶性肿瘤、甲状腺功能亢进等消耗性疾病。检测如下六项指标(1)实际体重与标准体重百分比(%IBW);(2)血清白蛋白(ALB);(3)外周血淋巴细胞计数(TLC)=淋巴细胞百分数X白细胞计数; (4)肺功能:用意大利进口肺量计,检测第1秒用力呼气量(FEV1),并计算第1秒用力呼气量与用力肺活量百分比(FEV1%); (5)用血气分析仪测定患者的动脉血PH值、氧分压(P02)、二氧化碳分压(PC02);(6)住院天数。依据轻度: FEV1 / FVC < 70 %、FEV1≥80 %预计值,有或无慢性咳嗽、咳痰症状;极重度: FEV1 / FVC < 70 %、FEV1 < 30 %预计值,或FEV1 < 50 %预计值,并伴有慢性呼吸衰竭或右心衰竭临床表现,将慢性阻塞性肺病分为轻度及极重度两组,对比分析其营养、免疫、肺功能、血气及住院情况。
结果:实际体重占理想体重的百分比(%IBW)、一秒用力呼气量(FEV1)及FEV1和用力肺活量(FVC)百分比、动脉血二氧化碳分压(PCO2)、住院天数两组之间有显著性差异(P<0.05)。
结论:慢性阻塞性肺病患者的营养状况和病情严重程度密切相关,加强慢性阻塞性肺病患者的营养状况可改善其预后。
Chronic obstructive pulmonary disease (COPD) is a kind of disease that could be prevented and treated, and it holds a characteristics that the airflow can berestricted .But the airflow limitation was not fully reversible ,it develops progressively, in relation to the lung's abnormal inflammations reaction to the harmful gases and harmful particles . Because of its high morbidity and mortality, and there is an increasing trend year by year, COPD has serious negative impact on the labor force and quality of life. COPD is currently the world's fourth cause of death, the World Bank / WHO announced COPD will be the fifth financial burden of the diseases in the world's by 2020 . In our country COPD is also an important chronic respiratory diseases which seriously endangers the health of the people, and is the most common cause leading to chronic respiratory failure and chronic pulmonary heart disease . The main damage of COPD is in lung ,but it may also cause the systemic effects . To chronic obstructive pulmonary disease patients, their exercise endurance was reduced, activity was restricted, quality of life was decreased. Recent study found that in COPD patients skeletal muscle dysfunction and weight loss are widespread, and is associated with lower endurance exercise. Non-fat weight loss of patients with COPD can affect the respiratory muscles and peripheral muscle function, exercise capacity, health status and prognosis. Reducing body mass index in patients with acute exacerbation of COPD is a bad indicator, increase their hospitalization rate, mortality and rate of mechanical ventilation, and the survival time Closely related to their body mass index .
Acute stage in patients with chronic obstructive pulmonary disease has often accompanied by malnutrition, incidence of it is up to 50.6% ~ 69.9% and the weight loss is its outstanding performance , 60 percent of them weight less than ideal body weight, by the chronic long-term consumption of basic pulmonary disease or absorption barriers, reduce consumption or acute severe lung infection caused by the high metabolic state, manifested as respiratory muscle atrophy, decreased contractile force, endurance and reduce the pulmonary defense functional decline, etc.. Surfactant reduced, and thus easy to alveolar collapse, and severe malnutrition make the respiratory center,s reactivity to hypoxia and hyperpyemia reduce, all the above are easily induced by respiratory failure. In addition, the patient with mechanical ventilation will become difficult to remove the machince. Therefore, nutrition therapy for chronic obstructive pulmonary disease patients with respiratory failure is an important instrument.
Objective: To investigate the acute exacerbation of chronic obstructive pulmonary disease in patients with nutritional status on immune function and ventilation, as well as provide the basis for the treatment of nutritional support for patients with chronic obstructive pulmonary disease who has respiratory failure, conduct effective nutrition intervention, and thus improve their quality of life, reduce the incidence of the number.
Methods: From March 2008 to March 2009 ,there were 53 patients who were by AECOPD due to China-Japen Union Hospital of Jilin University,and except patient with liver, kidney, digestive tract diseases and tuberculosis, cancer, hyperthyroidism etc. The definition of acute exacerbation of the COPD is the continued deterioration beyond the day-to-day situation and the COPD patients who need to change the basis of the conventional drug , in the disease process, patients usually with the aggravation of cough、sputum、shortness of breath and (or) pant in short-term, the increase of sputum volume ,in viscosity purulent or purulent, inflammation may be associated with fever. COPD in line with the diagnosis and treatment guidelines of Chronic Obstructive Pulmonary Disease Study Group which is attached to the Pulmonary Disease Study Group of Chinese Medical Association to set down in 2007.Detected the following six index:(1) the percentage of actual body weight to standard body weight (% IBW); (2) serum albumin (ALB); (3) peripheral blood lymphocyte count (TLC) = lymphocyte percentage X white blood cell count;: (4) pulmonary function and blood gas analysis: Using Italy spirometer to detect the first one second forced expiratory volume (FEV1), and calculate percentage of the first 1 second forced expiratory volume to FVC (FEV1%); (5) by blood gas analyzer Determination of arterial blood in patients with PH value, partial pressure of oxygen (P02), carbon dioxide partial pressure (PC02); (6) hospital day(HOD). Based on mild: FEV1 / FVC <70%, FEV1≥80% expected value, with or without chronic cough and expectoration symptoms; severe: FEV1 / FVC <70%, FEV1 <30% expected value, or FEV1 <50% expected value, and with chronic respiratory failure or clinical manifestations of right heart failure, chronic obstructive pulmonary disease will be divided into mild and severe groups, the comparative analysis of its nutrition, immunization, lung function and blood gas situation.
Results: The actual body weight accounted for the percentage of ideal body weight (% IBW), forced expiratory volume in one second (FEV1) and FEV1 to forced vital capacity (FVC) percentage,rterial carbon dioxide partial pressure (PCO2),hospital day (HOD)between the two groups were significantly different (P <0.05).
Conclusion: 1. COPD is a high incidence of common, frequently-occurring disease, and is often accompanied by malnutrition, in the acute stage due to nutrient digestion and absorption barriers, reducing consumption and increasing consumption, malnutrition is more serious.
2. Chronic obstructive pulmonary disease patients with the nutritional status of their cellular immune function and respiratory muscle strength and severity of disease are closely related, with the airway resistance in patients with the progressive increase in respiratory muscle must accompanied by the respiratory function improve, that is easy, following energy consumption , heat demand for a more timely manner to the corresponding supplement, together with the causes of hypoxia, such as aggravated respiratory muscle deterioration in energy metabolism, resulting in negative energy balance, thus affecting the prognosis.
3. Acute exacerbation of COPD patients with timely and effective nutritional intervention can improve the patient's immune function and ventilation, and reduce mortality in patients.
引文
[1] Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary diseases surveillance-United States, 1971-2000. MMWR Surveill Summ, 2002;51(6):1-16.
[2]全国COPD流行病学调查研究课题组.我国慢性阻塞性肺疾病发病的主要危险因素研究.中华医学会第七次呼吸病学术会议暨学习班论文汇编.2006.
[3]叶任高,陆再英主编.内科学.第6版.北京:人民卫生出版社,2005. 60-61.
[4] Petty TL. Chronic obstructive pulmonary disease 2can we do better. Chest ,1990 ,97 :2s-5s.
[5]慢性阻塞性肺疾病(COPD)诊治指南.中华结核和呼吸杂志,2007;46(3): 254-260.
[6]陈嘉馨.营养支持对急性期COPD患者免疫功能的影响.肠外营养与肠内营养,2004 ,11 (3) :178.
[7]徐卫国.慢性阻塞性肺部疾病的营养需要和供给.国外医学内科学分册,1994 ,21 (5) :200.
[8]李彩萍,刘晓晴,黄骁燕,等.老年慢性阻塞性肺病急性期的营养治疗.中国康复,2004 ,19 (3) :161.
[9]林江涛.缓解期慢性阻塞性肺病患者的营养状态与营养治疗[J].中华结核和呼吸杂志,1996,19(5) :261-264
[10]孙银香.口服营养在慢性阻塞性肺病缓解期的应用研究[J].中国康复医学杂志,1996,11(2) :52-55
[11]包红,李清华,罗白灵.营养支持对慢性阻塞性肺病急性加重期患者免疫和肺功能的影响.中华急诊医学杂志,2003 ,12(11) :732.
[12]赵昌峻.慢性阻塞性肺部疾病的营养支持.临床营养诊断和治疗.杭州:浙江科学技术出版社,2000. 16.
[13]彭敏,蔡柏强.美国胸科协会和欧洲呼吸协会对慢性阻塞性肺疾病诊治指南的修订.中华内科杂志,2005 ,44 (5) :394-397.
[14] Laaban J P. Nutrition and chronic respiratory failure. Ann Meel Intern , 2000 ,151 :542-548.
[15] Ezzell L ,J ensen GL. Malnutrition in chronic obstructive pulmonary disease. AM J Clin Nutrition ,2000 ,72 :1415-1416.
【1】NHLBFWHO专题研讨会工作报告.慢性阻塞性肺疾病的诊断、治疗和预防的全球策略.2001年4月。
【2】Mannino DM, Homa DM, Akinbami LJ, etal. Chronic obstructive pulmonary diseases surveillance-United States, 1971-2000. MMWR Surveill Summ, 2002;51(6):1-16.
【3】Mannino DM.,COPD:epidemiology,prevalence,morbidity and mortality and disease heterogeneity.Chest,2002;121:121S-126S.
【4】.全国COPD流行病学调查研究课题组.我国慢性阻塞性肺疾病发病的主要危险因素研究.中华医学会第七次呼吸病学术会议暨学习班论文汇编.2006
【5】Bemard S , LeBlanc P , Whittom F , et al . Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,1998 ,158 (2) :629-634.
【6】Serres I , Gautier V , Varray A , et al . Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest ,1998 ,113(4) :900-905.
【7】Mador MJ , Kufei TJ , Pineda L. Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,2000 ,161 (2) :447-453.
【8】Mador MJ , Kute TJ , Pineda LA , et al . Effect of pulmonary rehabilitation on quadriceps fatigability during exercise. Am J Respir Crit Care Med ,2001 ,163 (4) :930-935.
【9】Mador MJ , Kufe TJ , Pineda LA. Quadriceps and diaphragmatic function after exhaustive cycle exercise in the healthyelderly. Am J Respir Crit Care Med ,2000 ,162 (5) :1760-1766.
【10】Whittom F , Jobin J , Simard PM , et al . Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc ,1998 ,30 (5) :1467-1474.
【11】Maltais F ,Sullivan M J ,LeBianc P ,et al . Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J ,1999 ,13 (4) :850-854.
【12】Jobin J , Maitais F , Doyon J F , et al . Chronic obstructive pulmonary disease capillarity and fiber2 type characteristics of skeletal muscle. J Cardiopulm Rehab ,1998 ,18 (2) :432-437.
【13】Sauleda J , Garcia2Palmer F , Wiesner PJ , etal . Cytochromeoxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med ,1998 ,157 (5) :1413-1417.
【14】Sale E ,Roca J ,Marrades RM ,et al . Effects of endurance training on skeletal muscle bioenergetics in chronic obsructive pulmonary disease. Am J Respir Crit Care Med ,1999 ,159 (6) :1726-1734.
【15】Maltais F , Jobin J , Sullivan MJ , et al . Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol ,1998 ,84 (5) :1573-1580.
【16】McLoughlin DM , Spargo E , Wassif WS , et al . Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropat hol ,1998 ,95 (2) :632-640.
【17】Sauleda J , Garcia2Palmer FJ , Gonzalez G, et al . The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease , asthma ,and chronicarthritis. Am J Respir Crit Care Med ,2000 ,161 (1) :32-35.
【18】Sauleda J , Garcia2Palmer F , Wiesner RJ , et al . Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med ,1998 ,157 (5 Pt1) :1413-1417.
【19】Lundberg I , Kratz A K, Alexanderson H , et al . De2 creased expression of interleukin21α, interleukin21β,and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositi[J].Arthritis Rheum ,2000 ,43 :336-348.
【20】Speiser P ,Zeillinger R , Wilt schke C , et al . IL21αin2 duced ,TNF alpha mediated HLA classⅡ(DR) antigen up2regulation in a human ductal breast carcinoma cell line ZR27521[J ] . Neoplasma , 1993 ,40 :137-140.
【21】Authier FJ , Mhiri C , Chazaud B , et al . Interlukin21 expression in inflammatory myopathies : evidence of marked immunore activity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes[ J ] . Neuopathol Appl Neurobiol , 1997 , 23 :132-140.
【22】Fang CH , Li BG, James J H , et al . Cytokine block the effects of insulin2like growth factor2Ⅰ( IGF2Ⅰ) on glacose uptake and lactate production in skeletal mus2cle but not influence IGF2 Ⅰ2induced changes in pro2tein turnover [J ] . Shock , 1997 ,8 :362-367.
【23】J i SQ , Neustrom S , Willis GM , et al . Proinflammato2ry cytokines regulate myogenic cell proliferation and fusion but have no impact on myotube protein metabo2lism or stress protein expression[J ] . J Interferon Cy2 tokine Res , 1998 ,18 :879-888.
【24】Engelen MP , Schols AM , Does JD , et al . Skeletal muscleweakness is associated wit h wasting of extremity fat2 free mass but not with airflow obstruction in patient s with chronic obstructive pulmonary disease. Am J Clin Nut r ,2000 ,71 (3) :733-738.
【25】Auwerx J ,Staels B. Leptin. Lancet ,1998 ,351 (9104) :737-742.
【26】Schols AM ,Creutzberg EC ,Buurman WA ,et al . Plasma leptin is related to proinflammatory status and dietary intake in patient s with chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,1999 ,160 (4) :1220-1226.
【27】Niewoehner DE , Erbland ML , Deupree RH , et al . Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group . N Engl J Med ,1999 ,340 (25) :1941-1947.
【28】Creutzberg EC ,Wouters EF ,Vanderhoven2Augustin IM , et al .Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,2000 ,162 (4 Pt1) :1239-1245.
【29】Nguyen L T ,Bedu M ,Caillaud D ,et al . Increased resting energy expenditure is related to plasma TNF2alpha concent ration in stable COPD patient s. Clin Nut r ,1999 ,18 (5) :269-274.
【30】Engelen MP ,Deutz NE ,Wouters EF , et al . Enhanced level s of whole2body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,2000 ,162 (4Pt1) :1488-1492.
【31】Bernard S , LeBlanc P , Whit tom F , et al . Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,1998 ,158 (2) :629-634.
【32】Nagaraju K, Casciola2Rosen L, Rosen A et al. The inhibition of apoptosis in myositis and in normal muscle cells[ J ]. J Immunol, 2000, 164 (10) : 5459-5465.
【33】Tschopp J, IrmlerM, ThomeM. Inhibition of Fas death signals by FL IPs[ J ]. CurrOpin Immunol, 1998, 10 (6) : 552-558.
【34】Nagaraju K. Update on immune opathogenesis in inflammatory my2opathies[ J ]. CurrOpin Rheumatol, 2001, 13 (5) : 461-468.
【35】LiM,DalakasMC. Expression of human IAP2like protein in skel2etal muscle: a possible explanation for the rare incidence of mus2cle fiber apoptosis in T2cell mediated inflammatory my2opathies [ J ]. J Neuro immunol, 2000, 106 (1) : 125.
【36】Vattemi G, Tonin P, FilostoM et al. T2cell anti2apop tosismech2 anisms in inflammatory my2opathies[ J ]. J Neuroimmunol, 2000,111 (2) : 146-151.
【37】Newman ED , Kurland RJ . P231 magnetic resonance spectroscopy in polymyositis and dermatmyositis[J ] .Arthritis Rheum , 1992 ,35 :199-203.
【38】Park J H , Olsen NJ , King L J r , et al . Use of magnetic resonance imaging and P231 magnetic resonance spec2troscope to detct and quantify muscle dysfunction in the amyopathic and myopathic variant s of derm2 atom2 yositis[J ] . Arthritis Rheum ,1995 ,38 :68-77.
【39】Chariot P , Ruet E , Authier FJ , et al . Cytochrome coxidase deficiencies in the muscle of patient s with in2flammatory myopathies[J ] . Acta Neuropathol , 1996 ,91 :530-536.
【40】Shreeniwas R , Koga S , Karakurum M , et al . Hypoxi2a2 mediated induction of endothelial cell interleukin21 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface [J ] . J Clin Invest , 1992 ,90 :2333-2339.
[2]全国COPD流行病学调查研究课题组.我国慢性阻塞性肺疾病发病的主要危险因素研究.中华医学会第七次呼吸病学术会议暨学习班论文汇编.2006.
[3]叶任高,陆再英主编.内科学.第6版.北京:人民卫生出版社,2005. 60-61.
[4] Petty TL. Chronic obstructive pulmonary disease 2can we do better. Chest ,1990 ,97 :2s-5s.
[5]慢性阻塞性肺疾病(COPD)诊治指南.中华结核和呼吸杂志,2007;46(3): 254-260.
[6]陈嘉馨.营养支持对急性期COPD患者免疫功能的影响.肠外营养与肠内营养,2004 ,11 (3) :178.
[7]徐卫国.慢性阻塞性肺部疾病的营养需要和供给.国外医学内科学分册,1994 ,21 (5) :200.
[8]李彩萍,刘晓晴,黄骁燕,等.老年慢性阻塞性肺病急性期的营养治疗.中国康复,2004 ,19 (3) :161.
[9]林江涛.缓解期慢性阻塞性肺病患者的营养状态与营养治疗[J].中华结核和呼吸杂志,1996,19(5) :261-264
[10]孙银香.口服营养在慢性阻塞性肺病缓解期的应用研究[J].中国康复医学杂志,1996,11(2) :52-55
[11]包红,李清华,罗白灵.营养支持对慢性阻塞性肺病急性加重期患者免疫和肺功能的影响.中华急诊医学杂志,2003 ,12(11) :732.
[12]赵昌峻.慢性阻塞性肺部疾病的营养支持.临床营养诊断和治疗.杭州:浙江科学技术出版社,2000. 16.
[13]彭敏,蔡柏强.美国胸科协会和欧洲呼吸协会对慢性阻塞性肺疾病诊治指南的修订.中华内科杂志,2005 ,44 (5) :394-397.
[14] Laaban J P. Nutrition and chronic respiratory failure. Ann Meel Intern , 2000 ,151 :542-548.
[15] Ezzell L ,J ensen GL. Malnutrition in chronic obstructive pulmonary disease. AM J Clin Nutrition ,2000 ,72 :1415-1416.
【1】NHLBFWHO专题研讨会工作报告.慢性阻塞性肺疾病的诊断、治疗和预防的全球策略.2001年4月。
【2】Mannino DM, Homa DM, Akinbami LJ, etal. Chronic obstructive pulmonary diseases surveillance-United States, 1971-2000. MMWR Surveill Summ, 2002;51(6):1-16.
【3】Mannino DM.,COPD:epidemiology,prevalence,morbidity and mortality and disease heterogeneity.Chest,2002;121:121S-126S.
【4】.全国COPD流行病学调查研究课题组.我国慢性阻塞性肺疾病发病的主要危险因素研究.中华医学会第七次呼吸病学术会议暨学习班论文汇编.2006
【5】Bemard S , LeBlanc P , Whittom F , et al . Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,1998 ,158 (2) :629-634.
【6】Serres I , Gautier V , Varray A , et al . Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest ,1998 ,113(4) :900-905.
【7】Mador MJ , Kufei TJ , Pineda L. Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,2000 ,161 (2) :447-453.
【8】Mador MJ , Kute TJ , Pineda LA , et al . Effect of pulmonary rehabilitation on quadriceps fatigability during exercise. Am J Respir Crit Care Med ,2001 ,163 (4) :930-935.
【9】Mador MJ , Kufe TJ , Pineda LA. Quadriceps and diaphragmatic function after exhaustive cycle exercise in the healthyelderly. Am J Respir Crit Care Med ,2000 ,162 (5) :1760-1766.
【10】Whittom F , Jobin J , Simard PM , et al . Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc ,1998 ,30 (5) :1467-1474.
【11】Maltais F ,Sullivan M J ,LeBianc P ,et al . Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J ,1999 ,13 (4) :850-854.
【12】Jobin J , Maitais F , Doyon J F , et al . Chronic obstructive pulmonary disease capillarity and fiber2 type characteristics of skeletal muscle. J Cardiopulm Rehab ,1998 ,18 (2) :432-437.
【13】Sauleda J , Garcia2Palmer F , Wiesner PJ , etal . Cytochromeoxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med ,1998 ,157 (5) :1413-1417.
【14】Sale E ,Roca J ,Marrades RM ,et al . Effects of endurance training on skeletal muscle bioenergetics in chronic obsructive pulmonary disease. Am J Respir Crit Care Med ,1999 ,159 (6) :1726-1734.
【15】Maltais F , Jobin J , Sullivan MJ , et al . Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol ,1998 ,84 (5) :1573-1580.
【16】McLoughlin DM , Spargo E , Wassif WS , et al . Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropat hol ,1998 ,95 (2) :632-640.
【17】Sauleda J , Garcia2Palmer FJ , Gonzalez G, et al . The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease , asthma ,and chronicarthritis. Am J Respir Crit Care Med ,2000 ,161 (1) :32-35.
【18】Sauleda J , Garcia2Palmer F , Wiesner RJ , et al . Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med ,1998 ,157 (5 Pt1) :1413-1417.
【19】Lundberg I , Kratz A K, Alexanderson H , et al . De2 creased expression of interleukin21α, interleukin21β,and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositi[J].Arthritis Rheum ,2000 ,43 :336-348.
【20】Speiser P ,Zeillinger R , Wilt schke C , et al . IL21αin2 duced ,TNF alpha mediated HLA classⅡ(DR) antigen up2regulation in a human ductal breast carcinoma cell line ZR27521[J ] . Neoplasma , 1993 ,40 :137-140.
【21】Authier FJ , Mhiri C , Chazaud B , et al . Interlukin21 expression in inflammatory myopathies : evidence of marked immunore activity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes[ J ] . Neuopathol Appl Neurobiol , 1997 , 23 :132-140.
【22】Fang CH , Li BG, James J H , et al . Cytokine block the effects of insulin2like growth factor2Ⅰ( IGF2Ⅰ) on glacose uptake and lactate production in skeletal mus2cle but not influence IGF2 Ⅰ2induced changes in pro2tein turnover [J ] . Shock , 1997 ,8 :362-367.
【23】J i SQ , Neustrom S , Willis GM , et al . Proinflammato2ry cytokines regulate myogenic cell proliferation and fusion but have no impact on myotube protein metabo2lism or stress protein expression[J ] . J Interferon Cy2 tokine Res , 1998 ,18 :879-888.
【24】Engelen MP , Schols AM , Does JD , et al . Skeletal muscleweakness is associated wit h wasting of extremity fat2 free mass but not with airflow obstruction in patient s with chronic obstructive pulmonary disease. Am J Clin Nut r ,2000 ,71 (3) :733-738.
【25】Auwerx J ,Staels B. Leptin. Lancet ,1998 ,351 (9104) :737-742.
【26】Schols AM ,Creutzberg EC ,Buurman WA ,et al . Plasma leptin is related to proinflammatory status and dietary intake in patient s with chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,1999 ,160 (4) :1220-1226.
【27】Niewoehner DE , Erbland ML , Deupree RH , et al . Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group . N Engl J Med ,1999 ,340 (25) :1941-1947.
【28】Creutzberg EC ,Wouters EF ,Vanderhoven2Augustin IM , et al .Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,2000 ,162 (4 Pt1) :1239-1245.
【29】Nguyen L T ,Bedu M ,Caillaud D ,et al . Increased resting energy expenditure is related to plasma TNF2alpha concent ration in stable COPD patient s. Clin Nut r ,1999 ,18 (5) :269-274.
【30】Engelen MP ,Deutz NE ,Wouters EF , et al . Enhanced level s of whole2body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,2000 ,162 (4Pt1) :1488-1492.
【31】Bernard S , LeBlanc P , Whit tom F , et al . Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med ,1998 ,158 (2) :629-634.
【32】Nagaraju K, Casciola2Rosen L, Rosen A et al. The inhibition of apoptosis in myositis and in normal muscle cells[ J ]. J Immunol, 2000, 164 (10) : 5459-5465.
【33】Tschopp J, IrmlerM, ThomeM. Inhibition of Fas death signals by FL IPs[ J ]. CurrOpin Immunol, 1998, 10 (6) : 552-558.
【34】Nagaraju K. Update on immune opathogenesis in inflammatory my2opathies[ J ]. CurrOpin Rheumatol, 2001, 13 (5) : 461-468.
【35】LiM,DalakasMC. Expression of human IAP2like protein in skel2etal muscle: a possible explanation for the rare incidence of mus2cle fiber apoptosis in T2cell mediated inflammatory my2opathies [ J ]. J Neuro immunol, 2000, 106 (1) : 125.
【36】Vattemi G, Tonin P, FilostoM et al. T2cell anti2apop tosismech2 anisms in inflammatory my2opathies[ J ]. J Neuroimmunol, 2000,111 (2) : 146-151.
【37】Newman ED , Kurland RJ . P231 magnetic resonance spectroscopy in polymyositis and dermatmyositis[J ] .Arthritis Rheum , 1992 ,35 :199-203.
【38】Park J H , Olsen NJ , King L J r , et al . Use of magnetic resonance imaging and P231 magnetic resonance spec2troscope to detct and quantify muscle dysfunction in the amyopathic and myopathic variant s of derm2 atom2 yositis[J ] . Arthritis Rheum ,1995 ,38 :68-77.
【39】Chariot P , Ruet E , Authier FJ , et al . Cytochrome coxidase deficiencies in the muscle of patient s with in2flammatory myopathies[J ] . Acta Neuropathol , 1996 ,91 :530-536.
【40】Shreeniwas R , Koga S , Karakurum M , et al . Hypoxi2a2 mediated induction of endothelial cell interleukin21 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface [J ] . J Clin Invest , 1992 ,90 :2333-2339.